BridgeBio Submits FDA Application for Heart Failure Drug Acoramidis
BridgeBio Pharma has submitted a new drug application to the FDA for acoramidis to treat patients with transthyretin amyloid cardiomyopathy...
BridgeBio Pharma has submitted a new drug application to the FDA for acoramidis to treat patients with transthyretin amyloid cardiomyopathy...
By Express News Service MADURAI: Driven by the need to access healthcare for their five-year-old child with a heart condition,...
BYLINE: Noah Fromson Newswise — As the use of wearable technology grows, smart watches are marketed across the globe to...
Recognizing the need for predicting in-hospital cardiac arrest in critically ill patients, we developed and validated an ML-based prediction model...
As a cardiologist, I see this kind of scenario play out on a daily basis. A patient comes in for...
In a recent article published in Npj Digital Medicine, researchers utilized electrocardiogram (ECG) data from a large retrospective cohort to extract various...
As the winner of the American Heart Association's Annual Health Tech Competition, RCE.ai can now access resources and opportunities through...
CHICAGO, November 20, 2023--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), a leader in artificial intelligence-driven precision cardiovascular medicine tests, today...
New Delhi: A multi-specialty quaternary care hospital in the heart of the city has proved yet again that geographical boundaries...
There is increasing use of digital health solutions in heart failure, but few studies have demonstrated its impact on public...